Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS1354 Category:

The market for embolotherapy is forecast to reach USD 4.84 billion by 2024, growing from 2019 to 2024 at a CAGR of 8.12%. Growing incidences of peripheral vascular disorders, liver cancer, strokes, and uterine fibroids coupled with growing demand for minimally invasive procedures and technological advances in technology would boost market growth over the forecast period.

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 1

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 2

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 3

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 4

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 5

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 6

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 7

Embolotherapy Market by by Disease (Aneurysm, Oncology, Peripheral Vascular), by Product (Embolic Agents (Detachable Coils, Microspheres, Pushable Coils), Guidewires), by Procedure, End User (ASC, Academia, Hospitals, Clinics) - 2019 to 2024 8

1 Global Embolotherapy Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Embolotherapy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Embolotherapy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Embolotherapy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Embolotherapy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Embolotherapy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Embolotherapy Market – By Product (Market Size – & million/billion)
8.1 Embolic agents
8.2 Microspheres
8.3 Embolic coils
8.4 Liquid Embolic Agents
8.5 Embolic Plug Systems
8.6 Detachable Balloons
8.7 Others

9 Global Embolotherapy Market – By Disease Indication
9.1 Cancer
9.2 Liver Cancer
9.3 Kidney Cancer
9.4 Other Cancers
9.5 Peripheral Vascular Diseases
9.6 Neurological Diseases
9.7 Others

10 Global Embolotherapy Market – By Procedure
10.1 Transcatheter Arterial Embolization
10.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
10.3 Transarterial Chemoembolization

11 Global Embolotherapy Market – By End-User
11.1 Hospitals and Clinics
11.2 Ambulatory Surgical Centers
11.3 Other

12 Global Embolotherapy Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Embolotherapy Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Embolotherapy Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories
14.3 Acandis GmbH
14.4 Balt Extrusion
14.5 Boston Scientific Corporation
14.6 Medtronic PLC
14.7 Meril Life Sciences Pvt., Ltd.
14.8 BTG PLC
14.9 Johnson & Johnson
14.10 Cook Medical
14.11 Kaneka Corporation
14.12 Company 11 & more

15 Global Embolotherapy Market – Appendix
15.1 Sources
15.2 Abbreviations